SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-126152
Filing Date
2020-04-29
Accepted
2020-04-29 16:11:14
Documents
6
Period of Report
2020-06-17
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A d910899ddef14a.htm DEF 14A 1298580
2 GRAPHIC g910899g35s26.jpg GRAPHIC 93594
3 GRAPHIC g910899g36i66.jpg GRAPHIC 6692
4 GRAPHIC g910899g42a53.jpg GRAPHIC 89542
5 GRAPHIC g910899g64s91.jpg GRAPHIC 60628
6 GRAPHIC g910899g76l04.jpg GRAPHIC 116990
  Complete submission text file 0001193125-20-126152.txt   1795729
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24006 | Film No.: 20830398
SIC: 2834 Pharmaceutical Preparations